Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Watson-Marlow Pumps Group Acquires Bio Pure Technology Limited

Published: Tuesday, January 07, 2014
Last Updated: Monday, January 06, 2014
Bookmark and Share
WMPG strengthens its single-use biopharmaceutical offering through acquisition of Bio Pure.

Watson-Marlow has acquired Bio Pure through its parent company Spirax-Sarco Engineering plc for £8.5 million. Bio Pure, based in Portsmouth UK, specializes in the design and production of advanced single-use tubing connector systems for biopharmaceutical customers.

Bio Pure is a natural extension of the Watson-Marlow peristaltic pump range, complementing its offering in the Biopharmaceutical sector, and joining a portfolio comprising Watson-Marlow Pumps, Watson-Marlow Tubing, Flexicon Filling Systems, Alitea OEM Pumps MasoSine Process Pumps and Bredel Hose Pumps.

WMPG already has a positive commercial relationship with Bio Pure, jointly promoting Watson-Marlow pumps, tubing and Bio Pure connectors to shared customers, where both Bio Pure and Watson-Marlow products are integrated into customers’ equipment. There is clear synergy and a significant growth opportunity presented by bringing together Bio Pure’s product range and WMPG’s products to meet the needs of the rapidly growing single-use biopharmaceutical market.

The acquisition strengthens WMPG’s presence in the biotechnology and pharmaceutical industries. In particular, Bio Pure complements WMPG’s existing range of Flexicon peristaltic filling systems and single use tubing, easing customer validation in demanding contamination-free dispensing applications and offering improved sterility for critical applications.

Jay Whalen, President of the Watson-Marlow Pumps Group comments: "The strategic acquisition of Bio Pure further broadens our product range and strengthens Watson-Marlow's position in the single-use biopharmaceutical market. That enables us to provide a more comprehensive and improved service to our customer looking for sterility throughout their fluid path. This is yet another exciting milestone for Watson-Marlow and we are looking forward to accelerating our growth within the biopharmaceutical market with our broadened product portfolio coupled to our process expertise.”

Biopure was established in 1998 by the founder, Roy Maunder, who will continue with the company as a Non-Executive Director. We are pleased that Mr Steven Feasey will continue as Sales Director.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
Biomolecular Manufacturing ‘On-the-Go’
Wyss Institute team unveils a low-cost, portable method to manufacture biomolecules for a wide range of vaccines, other therapies as well as diagnostics.
Molecular Switch Aids Immune Therapy
Researchers identify strategy to maximise effectiveness of immune therapy through molecular switch controlling immune suppression.
Novavax RSV F Vaccine Fails Phase 3 Trial
Novavax announces topline RSV F Vaccine data from two clinical trials in older adults.
GSK’s Shingles Vaccine Candidate Shows High Efficacy
The vaccine candidate showed high efficacy against shingles and its complications in adults aged 70yrs+ in phase III study.
Eisai Establishes AiM Institute
The Andover innovative Medicines (AiM) Institute will develop innovative precision medicines for hard-to-treat conditions.
Antibodies that Target Holes in HIV's Defence Identified
Scientists suggest 'holes' in HIV sugar sheild can be targeted by antibodies.
Discovery Could Yield Improved Flu Vaccines
Researchers have discovered a type of immune antibody that can evolve to combat a number of infuenza virus strains.
First Accurate Simulation of a Virus Invading a Cell
For the first time, scientists know what happens to a virus’ shape when it invades a host cell.Understanding how the virus shape specifically changes could lead to more effective anti-viral therapies.
Developing a Vaccine for Sexually Transmitted and Insect-Borne Zika Infections
Prokarium announce the beginning of a programme to develop an oral vaccine against Zika infection.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!